Highlights in Multiple Myeloma Treatment from EHA2021

Highlights in Multiple Myeloma Treatment from EHA2021

Saved in:

Bibliographic Details
Main Author:	Carmen de Ramon Ortiz
Format:	Article
Language:	English
Published:	THE HEALTHBOOK COMPANY LTD. 2021-10-01
Series:	healthbook TIMES. Oncology Hematology
Online Access:	https://doi.org/10.36000/HBT.OH.2021.09.050
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Highlights in CAR T-Cell Therapy from EHA2021: Paving the Way for Better Treatments
by: Federico Simonetta
Published: (2021-10-01)

Highlights in Multiple Myeloma from ASH 2021
by: Rouven Müller
Published: (2022-03-01)

CLL and Lymphoma Studies at EHA2021 and 16-ICML
by: Davide Rossi
Published: (2021-10-01)

Assessment and Treatment of Elderly Patients with Multiple Myeloma
by: Carmen de Ramon Ortiz, et al.
Published: (2024-06-01)

Emerging therapeutic agents in multiple myeloma: highlights from the 2024 ASH annual meeting
by: Qing Zhang, et al.
Published: (2025-07-01)

Practice-changing updates on multiple myeloma: highlights from the 2024 ASH annual meeting
by: Ioannis Ntanasis-Stathopoulos, et al.
Published: (2025-05-01)

Recent Progress in Immunotherapy for RRMM: Updates from EHA 2023 Congress
by: María-Victoria Mateos
Published: (2023-06-01)

Osteosclerosing multiple myeloma: A case highlighting critical value of image findings for the diagnosis
by: Yuko Kobashi, et al.
Published: (2025-01-01)

EBMT-EHA 6th European CAR T-Cell Meeting 2024: Advancing Treatments and New Frontiers
by: Jana van den Berg, et al.
Published: (2024-06-01)

Revealing ‘Eha: A Qualitative Project on Historical Trauma Experiences Among Wāhine
by: Samantha Keaulana, et al.
Published: (2024-12-01)

Stage-specific gene pair ratios highlight genes and mechanisms related to presymptomatic and symptomatic Multiple Myeloma
by: Grigoris Georgiou, et al.
Published: (2025-01-01)

Insights into very elderly multiple myeloma treatment from Kansai Myeloma Forum
by: Yusuke Okayama, et al.
Published: (2025-12-01)

Application of the Water-Based Electro-Hydraulic Actuator (EHA) to the Heavy-Duty Collaborative Robot
by: Ha-Gwon Song, et al.
Published: (2024-11-01)

Highlights in AL Amyloidosis from ASH 2021
by: Kaveh Samii
Published: (2022-03-01)

Highlights in Prostate Cancer from ESMO 2021
by: Ursula Vogl
Published: (2021-12-01)

Highlights in Gynecological Cancer from ESMO 2021
by: Christian Kurzeder
Published: (2021-12-01)

Atypical Presentation of Multiple Myeloma: From Heart Failure to Multiple Myeloma
by: Ainur Elliana Sohaimi, et al.
Published: (2024-10-01)

New Frontiers in the Treatment of Multiple Myeloma
by: Janice Jin Hwang, et al.
Published: (2006-01-01)

Chromothripsis in Treatment Resistance in Multiple Myeloma
by: Kyoung Joo Lee, et al.
Published: (2017-09-01)

Results of multiple myeloma treatment with bortezomib
by: T. I. Pospelova, et al.
Published: (2022-11-01)

Treatment of double-refractory multiple myeloma
by: S. V. Semochkin
Published: (2021-09-01)

Review of the Expert Council “Multiple myeloma: the era of monoclonal antibodies in the treatment of patients with multiple myeloma”
by: M. I. Akhmedov, et al.
Published: (2024-01-01)

Highlights in CAR T-Cell Therapy from ASH 2021: Potential Practice-Changing Treatments
by: Federico Simonetta
Published: (2022-03-01)

The Multiple Myeloma
by: Keivan Daneshvar, et al.
Published: (2024-03-01)

TREATMENT MANAGEMENT IN MULTIPLE MYELOMA WITH RENAL DISORDER
by: Meryem Sener
Published: (2025-07-01)

THE TREATMENT OF MULTIPLE MYELOMA PATIENTS NOT ELIGIBLE FOR ASCT
by: Anuj Mahindra, et al.
Published: (2010-05-01)

Lenalidomide in the Treatment of Lymphoproliferative Disorders and Multiple Myeloma
by: Anna Marina Liberati, et al.
Published: (2013-01-01)

Elotuzumab for Treatment of Multiple Myeloma (Literature Review)
by: OM Votyakova
Published: (2016-10-01)

Treatment of bone complications in multiple myeloma patients
by: V. V. Ptushkin
Published: (2022-11-01)

Time trends in multiple myeloma incidence and mortality across the BRICS from 1992 to 2021 and projection to 2046
by: Heng Zhang, et al.
Published: (2025-05-01)

Global, regional and national epidemiological trends of multiple myeloma from 1990 to 2021: a systematic analysis of the Global Burden of Disease study 2021
by: Linmin Zhuge, et al.
Published: (2025-01-01)

Progress of immune senescence in multiple myeloma treatment resistance
by: Yanan Jia, et al.
Published: (2025-03-01)

Selinexor’s Immunomodulatory Impact in Advancing Multiple Myeloma Treatment
by: Kereshmeh Tasbihi, et al.
Published: (2025-03-01)

The role of pomalidomide in treatment of relapse and refractory multiple myeloma
by: S. V. Voloshin, et al.
Published: (2022-01-01)

Immunotherapy for Multiple Myeloma
by: Nicolaus Kröger, et al.
Published: (2012-01-01)

Leptomeningeal metastasis of multiple myeloma
by: Cristiane Máximo da Silva, et al.
Published: (2021-03-01)

Global, regional, and national burden of multiple myeloma, 1990 to 2021 and predictions to 2035: an analysis of the Global Burden of Disease Study 2021
by: Xin Miao, et al.
Published: (2025-07-01)

Global, regional, and national burden of multiple myeloma from 1990 to 2021 and projections for 2040: a systematic analysis for the global burden of disease 2021 study
by: Yuying Wei, et al.
Published: (2025-04-01)

FROM MULTIPLE MYELOMA TO ACUTE MYELOID LEUKEMIA
by: Sevde Yazıcı Şahin, et al.
Published: (2024-12-01)

Impact of treatment delay of multiple myeloma bone disease on later myeloma-related skeletal events and outcome
by: Eskelinen Veera, et al.
Published: (2025-08-01)